Chronic Myelomonocytic Leukemia Completed Phase 2 Trials for Clofarabine (DB00631)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

DBCOND0028572 (Chronic Myelomonocytic Leukemia)Completed2 IdentifierTitlePurposeDrugs
NCT01101880Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative NeoplasmTreatment
NCT00299156Oral Clofarabine Study in Patients With Myelodysplastic SyndromeTreatment